|
2023
|
Invention
|
Persistance and linking of analytic products in big data environments.
Persistence and linking o... |
|
|
Invention
|
Transdermal delivery formulations.
A transdermal formulation for the delivery of one or more act... |
|
|
Invention
|
Nitric oxide-releasing device.
A device for generating nitric oxide is disclosed. The device is ... |
|
|
Invention
|
Approach to sustained production and delivery of nitric oxide and s-nitrosothiols.
A composition... |
|
|
Invention
|
Transdermal delivery formulations.
A transdermal formulation for the delivery of a nitric oxide ... |
|
|
Invention
|
Neoadjuvant chemotherapy induces breast cancer metastasis through a tmem-mediated mechanism.
Met... |
|
|
Invention
|
Monoclonal antibodies to arabinomannan (am), groel2, and lprg and methods of use. Provided are an... |
|
|
Invention
|
Rna tagging system for visualization of single mrna molecules.
An RNA tagging system for visuali... |
|
|
Invention
|
Circulating levels of mirna-24 predict cerebrovascular events in covid-19. Provided herein are co... |
|
|
Invention
|
Flt3 ligand bi-functional molecules for thrombopenia and acute radiation syndrome. Provided herei... |
|
|
Invention
|
Hsv gene expression vector and bxb1 integrase-mediated recombination system for high-throughput c... |
|
|
Invention
|
Chimeric antigen receptors comprising a tmigd2 costimulatory domain and associated methods of usi... |
|
|
Invention
|
High resolution intravital imaging and uses thereof.
Methods and apparatus are provided for high... |
|
|
Invention
|
Platform technology for bispecific antigen-binding proteins. Provided herein is a novel platform ... |
|
|
Invention
|
Recombinant herpes simplex virus 2 (hsv-2) vectors and engineered transgenic vero cell lines. A r... |
|
|
Invention
|
Exhaled micrornas for the detection of human lung pathology. Provided herein are compositions and... |
|
|
Invention
|
Targeting an enzyme required for acute myeloid leukemia. Compositions and methods are provided fo... |
|
|
Invention
|
Methods for producing red blood cells. This disclosure is based, at least in part, on the unexpec... |
|
|
Invention
|
Transdermal delivery formulations. A transdermal formulation for the delivery of a nitric oxide b... |
|
|
Invention
|
Circulating levels of endothelial microrna-155 predict new-onset diabetes in covid-19 and long co... |
|
|
Invention
|
A gene-based approach to confer long-lasting protection from opioid use disorder. A composition a... |
|
|
Invention
|
Methods and compositions for assessing germline risk of cancer.
Heritable mutations in the BRCA1... |
|
|
Invention
|
Herpes virus entry mediator proteins and methods of use thereof. inter aliainter alia, are compos... |
|
2022
|
Invention
|
Methods of treatment by targeting vcam1 and maea.
Antibodies and antibody fragments that inhibit... |
|
|
Invention
|
Fusion constructs optically controllable by far red light and methods of use thereof. e.g.e.g., D... |
|
|
Invention
|
Mitofusin inhibitors and uses thereof. Disclosed herein are mitofusin inhibitors which are capabl... |
|
|
Invention
|
Hsv-2-delta-gd vaccines and methods for their production and use.
Recombinant herpes simplex vir... |
|
|
Invention
|
Cell impermeable kinase inhibitors to treat sars-cov-2 and/or hsv viral infections. Methods of pr... |
|
|
Invention
|
Method for measuring somatic dna mutation and dna damage profiles and a diagnostic kit suitable t... |
|
|
Invention
|
Methods, compositions, and kits for modifying immune cell activity via kir2dl5. Provided herein a... |
|
|
Invention
|
Expanding t-cell using mitofusin activators and uses in cancer therapies. This disclosure relates... |
|
|
Invention
|
Omega muricholic acid as a pregnane x receptor ligand for treating hepato-intestinal diseases.
M... |
|
|
Invention
|
Methods of increasing progenitor cell production.
Methods of increasing progenitor cell producti... |
|
|
Invention
|
Antagonist antibodies against human immune checkpoint ceacam1 (cd66a) and formulations, kits, and... |
|
2021
|
Invention
|
High-affinity mycobacterium tuberculosis capsule-specific human monoclonal antibody.
Provided ar... |
|
|
Invention
|
Method for predicting patient response to cd40-targeted therapies.
Methods of predicting respons... |
|
|
Invention
|
Reporter mycobacteriophage, assays and methods comprising the reporter mycobacteriophage.
A repo... |
|
|
Invention
|
Methods of treating viral infections with pirnas or extracellular vessicles released from neural ... |
|
|
Invention
|
Combination therapy using bax activator agent.
A pharmaceutical combination comprising a B-cell ... |
|
|
Invention
|
Compounds and methods for inhibition of bax-mediated cell death.
This disclosure provides novel ... |
|
|
Invention
|
N-cyclyl-sulfonamides useful for inhibiting raf.
This disclosure provides compounds and pharmace... |
|
|
Invention
|
Agents to prevent tissue damage from clostridium difficile infections by inhibition of the gut-da... |
|
|
Invention
|
Inhibition of bax-mediated cell death by eltrombopag.
This disclosure provides methods for inhib... |
|
|
Invention
|
Compositions and methods for using transplanted microglia as a vehicle for widespread delivery of... |
|
|
Invention
|
Method of treating and preventing ocular disease with hsv-2 delta gd.
Methods of treating or pre... |
|
|
Invention
|
Compositions and methods for chimeric antigen receptor (car)-modified cell modulation.
Polypepti... |
|
|
Invention
|
A method to generate chimeric antigen receptor (car) t-cells (car-t cells) from pathogen-specific... |
|
2018
|
Invention
|
Characterization of s-adenosyl-l-methionine-consuming enzymes with 1-step ez-mtase: a universal ... |
